SC&H Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$512K Hold
1,021
0.07% 95
2026
Q1
$502K Hold
1,021
0.08% 91
2025
Q4
$592K Hold
1,021
0.09% 88
2025
Q3
$495K Hold
1,021
0.08% 90
2025
Q2
$414K Hold
1,021
0.07% 98
2025
Q1
$508K Hold
1,021
0.1% 87
2024
Q4
$531K Sell
1,021
-171
-14% -$94K 0.11% 89
2024
Q3
$737K Buy
1,192
+4
+0.3% +$2.37K 0.16% 79
2024
Q2
$657K Hold
1,188
0.16% 80
2024
Q1
$690K Sell
1,188
-160
-12% -$89.8K 0.18% 77
2023
Q4
$715K Sell
1,348
-132
-9% -$63.9K 0.21% 69
2023
Q3
$749K Hold
1,480
0.25% 67
2023
Q2
$772K Sell
1,480
-1
-0.1% -$540 0.26% 70
2023
Q1
$854K Buy
1,481
+173
+13% +$97.5K 0.31% 62
2022
Q4
$720K Sell
1,308
-160
-11% -$84.8K 0.3% 69
2022
Q3
$744K Sell
1,468
-181
-11% -$101K 0.37% 56
2022
Q2
$896K Buy
1,649
+170
+11% +$93.6K 0.42% 51
2022
Q1
$873K Sell
1,479
-5
-0.3% -$2.87K 0.42% 55
2021
Q4
$990K Buy
+1,484
New +$927K 0.55% 42

Other funds holding TMO

SC&H Financial Advisors's TMO Position: Q2 2026 in Review

SC&H Financial Advisors held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 1,021 shares worth $512K. The position accounts for 0.07% of the portfolio, ranked #95.

SC&H Financial Advisors first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. The position peaked at $990K in Q4 2021. 2,617 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • SC&H Financial Advisors held 1,021 shares of Thermo Fisher Scientific worth $512K as of Q2 2026.
  • SC&H Financial Advisors left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.07% of SC&H Financial Advisors's portfolio in Q2 2026, its #95 holding.
  • SC&H Financial Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
  • SC&H Financial Advisors's Thermo Fisher Scientific position peaked at $990K in Q4 2021.
  • 2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on SC&H Financial Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.